The market of life science tools and technology providers has undergone only a few changes since the last time GEN published this list more than a year ago. Some of the major driving factors for the growth of the life sciences tools market include rising demand from various research and pharmaceutical companies, the increasing incidence of new and drug-resistant diseases, and technological advancement in the various life science fields, according to a report from Transparency Market Research.
But the changes to this year’s GEN listing are huge: Life Technologies has been acquired by Thermo Fisher Scientific for $13.6 billion, plus $1.5 billion in debt, in a deal completed February 2 of this year, while Complete Genomics’ $117.6 million acquisition by BGI Shenzhen was completed on March 18, 2013.
As a result, Life Tech and Complete Genomics aren’t within this year’s list of top 20 life sciences tools and technologies providers—a list that includes both companies and divisions of broader corporate giants as ranked by their R&D spending for 2012.
Listings include R&D spending for 2012 and 2011, the percentage difference between the two years, the percentage of sales for both years, and 2008 R&D spending and percentage of sales.